Ozempic® lowered A1C better
A 40-week study compared Ozempic® 0.5 mg with Trulicity® 0.75 mg and Ozempic® 1 mg with Trulicity® 1.5 mg in 1201 adults with type 2 diabetes who were taking metformin.
The most common side effects of Ozempic® may include nausea, vomiting, diarrhea, stomach (abdominal) pain, and constipation.
51%
of people with a starting A1C of 8.2% who took 0.75 mg Trulicity® lowered their A1C below 7%
vs
65%
of people with a starting A1C of 8.3% who took 0.5 mg Ozempic® lowered their A1C below 7%
63%
of people with a starting A1C of 8.2% who took 1.5 mg Trulicity® lowered their A1C below 7%
vs
73%
of people with a starting A1C of 8.2% who took 1 mg Ozempic® lowered their A1C below 7%
Ozempic® lowered A1C better
A 56-week study compared Ozempic® 1 mg with Bydureon® 2 mg in 813 adults with type 2 diabetes, in combination with metformin or metformin with sulfonylurea.
The most common side effects of Ozempic® may include nausea, vomiting, diarrhea, stomach (abdominal) pain, and constipation.
40%
of people with a starting A1C of 8.3% who took Bydureon® 2 mg lowered their A1C below 7%
vs
62%
of people with a starting A1C of 8.4% who took Ozempic® 1 mg lowered their A1C below 7%
A 56-week study compared Ozempic® 0.5 mg and 1 mg with Januvia® 100 mg in 1231 adults with type 2 diabetes when both were added to 1 or more diabetes pills.
The most common side effects of Ozempic® may include nausea, vomiting, diarrhea, stomach (abdominal) pain, and constipation.
40%
of people with a starting A1C of 8.2% who took Januvia® 100 mg lowered their A1C below 7%
vs
66%
of people with a starting A1C of 8.0% who took Ozempic® 0.5 mg lowered their A1C below 7%
vs
73%
of people with a starting A1C of 8.0% who took Ozempic® 1 mg lowered their A1C below 7%
Ozempic® lowered A1C more than dose–adjusted Lantusa
A 30-week study compared Ozempic® 0.5 mg and 1 mg with Lantus® in 1089 adults with type 2 diabetes when both were added to 1 or more diabetes pills.
aAt the end of the study, 26% of patients on Lantus® had their dose adjusted to their blood sugar goal (or target) by a health care professional. The average daily dose of Lantus® was 29 units per day by the end of the study.
The most common side effects of Ozempic® may include nausea, vomiting, diarrhea, stomach (abdominal) pain, and constipation.
40%
of people with a starting A1C of 8.1% who took Lantus® lowered their A1C below 7%
vs
55%
of people with a starting A1C of 8.1% who took Ozempic® 0.5 mg lowered their A1C below 7%
vs
66%
of people with a starting A1C of 8.2% who took Ozempic® 1 mg lowered their A1C below 7%
Ozempic® is not a weight-loss drug. It is a medicine for adults with type 2 diabetes that, along with diet and exercise, may improve blood sugar.
People lost more than double the weight on Ozempic® vs Trulicity®
Results are from a 40-week study that compared Ozempic® 0.5 mg with Trulicity® 0.75 mg and Ozempic® 1 mg with Trulicity® 1.5 mg in 1201 adults with type 2 diabetes who were taking metformin. While many people in clinical trials lost weight, some did gain weight. Ozempic® is not a weight-loss drug.
Selected Important Safety Information:
Ozempic® may cause serious side effects, including:
Results are from a 56-week study that compared Ozempic® 1 mg with Bydureon® 2 mg in 813 adults with type 2 diabetes in combination with metformin or metformin and sulfonylurea. While many people in clinical trials lost weight, some did gain weight. Ozempic® is not a weight-loss drug.
Ozempic® may cause serious side effects, including:
Results are from a 56-week medical study with 1231 adults with type 2 diabetes which compared Ozempic® with the leading branded pill, Januvia®, when both were added to one or more diabetes pills. While many people in clinical trials lost weight, some did gain weight. Ozempic® is not a weight-loss drug.
Ozempic® may cause serious side effects, including:
Results are from a 30-week study that compared Ozempic® 0.5 mg and 1 mg with Lantus® in 1089 adults with type 2 diabetes. While many people in clinical trials lost weight, some did gain weight. Ozempic® is not a weight-loss drug.
Ozempic® may cause serious side effects, including:
In a randomized 30-week study of 397 adults with type 2 diabetes, Ozempic® was proven to help people with type 2 diabetes lower their A1C when added to a treatment plan that included taking insulin with or without metformin.
Ozempic® may cause serious side effects, including low blood sugar (hypoglycemia). Your risk of getting low blood sugar may be higher if you use Ozempic® with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin. Signs and symptoms of low blood sugar may include: dizziness or lightheadedness, blurred vision, anxiety, irritability or mood changes, sweating, slurred speech, hunger, confusion or drowsiness, shakiness, weakness, headache, fast heartbeat, and feeling jittery.
Talk to your health care professional to find out if once-weekly Ozempic® is right for you. Download a discussion guide to help get you started.